SCHEMBL5322316

SCHEMBL5322316

CC(C)=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.54

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.54
LMNA P02545 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
KDM4E B2RXH2 2/20 0.43
USP2 O75604 1/20 0.40
SLCO1B1 Q9Y6L6 1/20 0.40
TOP1 P11387 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8718317 1.00 PDE4A (0.54) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL8722914 1.00 PDE4A (0.54) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL4001566 1.00 PDE4A (0.54) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL27579718 1.00 PDE4A (0.54) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL28131184 0.98 TDP1 (0.55) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL4744871 0.93 LMNA (0.48) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL8718440 0.93 LMNA (0.48) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL28231713 0.93 LMNA (0.48) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL7525631 0.93 LMNA (0.48) PDE4ALMNAL3MBTL1TDP1KDM4E
SCHEMBL13604627 0.86 PDE4A (0.54) PDE4ALMNAL3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025121420-A1 POLYCARBONATE AND METHOD FOR PRODUCING THE SAME AGC株式会社 2025-06-12 WO disclosed
WO-2007088559-A1 PROCESS FOR PRODUCING SUBSTITUTED SULPHOXIDES JUBILANT ORGANOSYS LIMITED (IN) 2007-08-09 WO disclosed
EP-1467968-A1 N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS Warner-Lambert Company LLC (US) 2004-10-20 EP disclosed
WO-2003062191-A1 N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS WARNER-LAMBERT COMPANY LLC (US) 2003-07-31 WO disclosed
EP-1175385-A1 D-MANNITOL DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS Pharmacor Inc. (CA) 2002-01-30 EP disclosed
EP-1082328-A1 PRODUCTION OF OPTICALLY ACTIVE PHOSPHOLANES BASF AKTIENGESELLSCHAFT (DE) 2001-03-14 EP disclosed
WO-2000066524-A1 D-MANNITOL DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS PHARMACOR INC. (CA) 2000-11-09 WO disclosed
EP-0971925-A1 PYRIMIDOPYRIMIDINE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2000-01-19 EP disclosed
WO-1999062917-A1 PRODUCTION OF OPTICALLY ACTIVE PHOSPHOLANES BASF AKTIENGESELLSCHAFT (DE) 1999-12-09 WO disclosed
WO-1998043974-A1 PYRIMIDOPYRIMIDINE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 1998-10-08 WO disclosed
WO-1998007653-A1 CHIRAL HYDRIDE COMPLEXES ZEELAND CHEMICALS, INC. (US) 1998-02-26 WO disclosed
US-4588824-A (S)-GLYCEROL-1,2-ACETONIDE FROM 1,2:5,6-DI-O-ISOPROPYLIDENE-D-MANNITOL, LEAD TETRAACETATE, ALKALI BOROHYDRIDE MERCK & CO., INC. (US) 1986-05-13 US disclosed
US-4408063-A FROM A SULFONYLOXY HALOALCOHOL MERCK & CO., INC. (US) 1983-10-04 US disclosed
US-4346042-A Preparation of epihalohydrin enantiomers MERCK & CO., INC. (US) 1982-08-24 US disclosed
EP-0006615-A1 Process for preparing epihalohydrin enantiomers MERCK & CO. INC. (US) 1980-01-09 EP disclosed